Shares of Canadian cannabis-products maker CannTrust drop, then rebound, after the company reveals a preliminary quarterly loss and announces new share issuance.
Talk among a mammoth field of presidential candidates about drug price controls and an expansion of Medicare isn't helping biotech and health care stocks.
As the healthcare sector sells off, it's time to look for attractive value. You don't have to go any further than Amgen.
Danaher reports first-quarter earnings that beat analysts' estimates though revises forward guidance on costs related to acquisition of GE's biopharma business.
Few parts of the market have more volatility than the small caps in this sector.
Healthcare giant Johnson & Johnson reports first-quarter earnings lower than a year earlier but still above analysts' forecasts.
Drugmaker Catalent reaches an agreement to buy closely held Paragon Bioservices, the latest deal in the burgeoning gene-therapy treatment space.
Here are updates on small biotech/biopharma names I have profiled before.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.